The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 10,101–10,200 of 31,469
Armato, J., DeFronzo, R. A., Abdul-Ghani, M., & Ruby, R. (2012) · Endocrine Practice · doi:10.4158/ep11194.or · Cited by 35
Is vitamin D status a determining factor for metabolic syndrome? A case-control study
Neyestani, T. R., Salekzamani, Majd, H. A., Houshiarrad, Kalayi, Shariatzadeh, & Gharavi (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s21061 · Cited by 35
Ramanathan, L., & Siegel, J. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12840 · Cited by 39
Perez‐Cornago, A., de la Iglesia, R., Lopez‐Legarrea, P., Abete, I., Navas‐Carretero, S., Lacunza, C. I., Lahortiga‐Ramos, F., Martínez‐González, M. Á., Martínez, J. A., & Zulet, M. Á. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-36 · Cited by 36
Rizk, F. H., Elshweikh, S. A. R., & El-Naby, A. Y. A. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0371 · Cited by 36
Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria
Park, S. E., Lee, N. S., Park, J. W., Rhee, E., Lee, W., Oh, K. W., Park, S. W., Park, C., & Youn, B. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0247 · Cited by 34
Sanctis, V. D. (2014) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2014.074 · Cited by 35
Bicycling to school improves the cardiometabolic risk factor profile: a randomised controlled trial
Østergaard, L. J., Børrestad, L. A. B., Tarp, J., & Andersen, L. B. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001307 · Cited by 35
Pscherer, S., Heemann, U. W., & Frank, H. (2010) · Diabetes Care · doi:10.2337/dc09-1381 · Cited by 36
Body mass index and waist circumference cutoffs to define obesity in indigenous New Zealanders
Taylor, R. W., Brooking, L. A., Williams, S., Manning, P. J., Sutherland, W. H. F., Coppell, K. J., Tipene‐Leach, D., Dale, K. S., McAuley, K. A., & Mann, J. I. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29317 · Cited by 35
de Luis, D. A., de la Fuente, B., Izaola, O., Conde, R., Gutiérrez, S., Morillo, M., & Torres, C. T. (2011) · PubMed · doi:10.1590/s0212-16112011000400024 · Cited by 36
ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat
Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., Cupples, L. A., Ordovás, J. M., McMonagle, J., Defoort, C., Lovegrove, J. A., Drevon, C. A., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008474 · Cited by 34
Johnston, L., Harris, S. B., Retnakaran, R. R., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0254 · Cited by 35
Ader, M., Stefanovski, D., Richey, J. M., Kim, S. P., Kolka, C. M., Ionut, V., Kabir, M., & Bergman, R. N. (2013) · Diabetes · doi:10.2337/db13-1215 · Cited by 35
Laclaustra, M., Hurtado-Roca, Y., Sendin, M., Leon, M., Ledesma, M., Andres, E. M., Fernández‐Ortíz, A., Güallar, E., Ordovás, J. M., & Casasnovas, J. A. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.09.007 · Cited by 35
Clinical and metabolic effects of drospirenone–estradiol in menopausal women: a prospective study
Gambacciani, M., Rosano, G. M. C., Cappagli, B., Pepe, A. E., Vitale, C., & Genazzani, A. R. (2010) · Climacteric · doi:10.3109/13697137.2010.520099 · Cited by 35
Ding, Q., Hayashi, T., Zhang, X., Funami, J., Ge, L., Li, J., Huang, X., Cao, L., Zhang, J., & Iguchi, A. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.03.005 · Cited by 35
Page‐Wilson, G., Meece, K., White, A. E., Rosenbaum, M. S., Leibel, R. L., Smiley, R. M., & Wardlaw, S. L. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00206.2015 · Cited by 36
El-Haleim, E. A. A., Bahgat, A. K., & Saleh, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.01.011 · Cited by 35
Prevalence of lipodystrophy in Thai-HIV infected patients.
Puttawong, S., Prasithsirikul, W., & Vadcharavivad, S. (2004) · PubMed · Cited by 35
Peterson, L. M., Matthews, K. A., Derby, C. A., Bromberger, J. T., & Thurston, R. C. (2016) · Health Psychology · doi:10.1037/hea0000288 · Cited by 34
Usui, T., Ninomiya, T., Nagata, M., Takahashi, O., Doi, Y., Hata, J., Fukuhara, M., Kitazono, T., Oike, Y., & Kiyohara, Y. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1548 · Cited by 35
Characteristics of metabolically obese, normal-weight women differ by menopause status
Choi, J. Y., Ha, H. S., Kwon, H., Lee, S., Cho, H., Yim, H. W., Lee, W., & Park, Y. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31825d26b6 · Cited by 35
Meijnikman, A. S., Block, C. E. M. D., Verrijken, A., Mertens, I. L., Corthouts, B., & Gaal, L. F. V. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.004 · Cited by 35
Serrano-Ferrer, J., Crendal, E., Walther, G., Vinet, A., Dutheil, F., Naughton, G. A., Lesourd, B., Chapier, R., Courteix, D., & Obert, P. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.006 · Cited by 36
Berezin, A. Е., Kremzer, A. A., Cammarota, G., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0605 · Cited by 35
Impact of insulin resistance on cardiac and vascular function
Novo, G., Manno, G., Russo, R., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.087 · Cited by 35
Warris, L. T., van den Akker, E. L. T., Bierings, M., van den Bos, C., Zwaan, C. M., Sassen, S. D. T., Tissing, W. J. E., Veening, M. A., Pieters, R., & van den Heuvel‐Eibrink, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158225 · Cited by 39
Nampoothiri, R. V., Duseja, A. K., Rathi, M., Agrawal, S., Sachdeva, N. K., Mehta, M., Dhaliwal, H. S., Dhiman, R. K., & Chawla, Y. K. (2017) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2017.12.005 · Cited by 36
Valsesia, A., Saris, W. H. M., Astrup, A. V., Hager, J., & Masoodi, M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137646 · Cited by 37
Kurinami, N., Sugiyama, S., Yoshida, A., Hieshima, K., MIYAMOTO, F., Kajiwara, K., Jinnouchi, T., & Jinnouchi, H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.018 · Cited by 36
Nonnuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice
Chambliss, K. L., Barrera, J. A., Umetani, M., Umetani, J., Kim, S. H., Madak‐Erdogan, Z., Huang, L., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Mineo, C., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1629 · Cited by 36
Nayak, M., Peinhaupt, M., Heinemann, Á., Eekhoff, E. M. W., van Mechelen, W., Desoyé, G., & van Poppel, M. N. M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.031 · Cited by 37
Khalil, A., Huffman, M. D., Prabhakaran, D., Osmond, C., Fall, C. H. D., Tandon, N., Ramakrishnan, L., Prabhakaran, P., Biswas, S. K. D., Ramji, S., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.180 · Cited by 35
Soori, R., Rezaeian, N., Khosravi, N., Ahmadizad, S., Taleghani, H. M., Jourkesh, M., & Stannard, S. R. (2017) · Science & Sports · doi:10.1016/j.scispo.2016.12.004 · Cited by 35
Gorgey, A. S., Khalil, R. E., Gill, R. S., O’Brien, L. C., Lavis, T. D., Castillo, T. A., Cifu, D. X., Savas, J. F., Khan, R., Cardozo, C. P., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014125 · Cited by 36
Khidr, E. G., Ali, S. S., Elshafey, M. M., & Fawzy, O. (2017) · Gene · doi:10.1016/j.gene.2017.05.010 · Cited by 35
Peixoto, T. C., de Moura, E. G., OLIVEIRA, E. B. D., Soares, P. N., Guarda, D. S., Bernardino, D. N., Ai, X. X., Rodrigues, V. D. S. T., de Souza, G. R., da Silva, A. J. R., et al. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1467-2 · Cited by 38
Luo, G., Huang, B., Qiu, X., Xiao, L., Wang, N., Gao, Q. F., Yang, W. Q., & Hao, L. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700087 · Cited by 35
A novel botanical formula prevents diabetes by improving insulin resistance
Kan, J., Velliquette, R. A., Grann, K., Burns, C. R., Scholten, J. D., Tian, F., Zhang, Q., & Gui, M. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1848-3 · Cited by 35
Philips, L., Visser, J., Nel, D. G., & Blaauw, R. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2657-5 · Cited by 38
Kim, D., Kim, W. K., Kwak, M., Chung, G. E., Yim, J. Y., & Ahmed, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186702 · Cited by 35
Engel, S., Tholstrup, T., Bruun, J. M., Astrup, A. V., Richelsen, B., & Raben, A. (2017) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0006-9 · Cited by 37
Mulvahill, J. S., Nicol, G. E., Dixon, D. J., Lenze, E. J., Karp, J. F., Reynolds, C. F., Blumberger, D. M., & Mulsant, B. H. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15129 · Cited by 35
Seferović, J. P., Tesic, M. B., Seferovic, P. M., Lalic, K. S., Jotić, A., Biering‐Sørensen, T., Giga, V. L., Stankovic, S. D., Milic, N. M., Lukić, L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19229-w · Cited by 35
Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity
Tsiompanidis, E., Siakavellas, S. I., Tentolouris, A., Eleftheriadou, I., Chorepsima, S., Manolakis, A. C., Oikonomou, K. A., & Tentolouris, N. (2018) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v9.i1.28 · Cited by 35
Insulin resistance predicts the risk of gingival/periodontal inflammation
Andriankaja, O. M., Muñoz‐Torres, F. J., Vivaldi, J., Leroux, B. G., Campos, M., JOSHIPURA, K. J., & Pérez, C. M. (2018) · Journal of Periodontology · doi:10.1002/jper.17-0384 · Cited by 35
Kim, J. H., Heo, J. S., Baek, K. S., Kim, S., Kim, J., Baek, K., Kim, K. E., & Sheen, Y. H. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.03.005 · Cited by 35
Glucose transporter‐1 ( GLUT ‐1) expression in psoriasis: correlation with disease severity
Hodeib, A., Neinaa, Y. M. E., Zakaria, S. S., & Alshenawy, H. A. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14037 · Cited by 35
Hägele, F. A., Büsing, F., Nas, A., Aschoff, J. K., Gnädinger, L., Schweiggert, R. M., Carle, R., & Bosy‐Westphal, A. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0031-3 · Cited by 41
Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease
Nam, K., Yun, H., Joo, Y. S., Kim, J., Lee, S.-M., Lee, C., Park, K. S., Park, J., Chang, T., Kang, E., et al. (2018) · Diabetes, obesity and metabolism · doi:10.1111/dom.13458 · Cited by 33
Mourya, A., Akhtar, A., Ahuja, S., Sah, S. P., & Kumar, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.056 · Cited by 35
Hruby, A., & Jacques, P. F. (2018) · Public Health Nutrition · doi:10.1017/s1368980018001854 · Cited by 37
Zapata‐Lamana, R., Henríquez‐Olguín, C., Burgos, C., Meneses‐Valdés, R., Cigarroa, I., Soto, C., Fernández-Elías, V. E., García-Merino, S., Ramírez‐Campillo, R., García‐Hermoso, A., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01287 · Cited by 35
The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis
Zhang, C.-S., Wang, L., Wang, R., Liu, Y., Song, L.-M., Yuan, J.-H., Wang, B., & Dong, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01308 · Cited by 38
Briet, C., Ilie, M. D., Kuhn, E., Maione, L., Brailly‐Tabard, S., Salenave, S., Cariou, B., & Chanson, P. (2018) · Endocrine · doi:10.1007/s12020-018-1797-8 · Cited by 35
El-Kader, S. M. A., & Al-Jiffri, O. H. (2018) · African Health Sciences · doi:10.4314/ahs.v18i4.5 · Cited by 37
Association between Cluster of Lifestyle Behaviors and HOMA-IR among Adolescents: ABCD Growth Study
Werneck, A. O., Agostinete, R. R., Cayres, S. U., Urban, J. B., Wigna, A., Chagas, L. G. D. M., Torres, W., & Fernandes, R. A. (2018) · Medicina · doi:10.3390/medicina54060096 · Cited by 35
Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan
Hsu, H., Hsu, P.-W., Cheng, M., Ito, Y., Kanda, E., Schaefer, E. J., & Ai, M. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48330 · Cited by 35
Serum catestatin concentrations are decreased in obese children and adolescents
Šimunović, M., Šupe‐Domić, D., Karin, Ž., Degoricija, M., Paradžik, M., Božić, J., Unic, I. J., & Škrabić, V. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12825 · Cited by 35
Zhao, J.-G., Wang, H.-Y., Wei, Z.-G., et al. (2019) · Toxicology Research · doi:10.1039/c8tx00294k · Cited by 35
Nyavor, Y., Estill, R., Edwards, H., Ogden, H., Heideman, K., Starks, K., Miller, C., May, G., Flesch, L., McMillan, J., et al. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03002-0 · Cited by 35
Dianthus superbus Improves Glomerular Fibrosis and Renal Dysfunction in Diabetic Nephropathy Model
Yoon, J. J., Park, J. H., Kim, H. J., Jin, H.-G., Kim, H. Y., Ahn, Y. M., Kim, Y. C., Lee, H. S., Lee, Y. J., & Kang, D. G. (2019) · Nutrients · doi:10.3390/nu11030553 · Cited by 35
Workeneh, B., Moore, L. W., Fong, J. N., Shypailo, R. J., Gaber, A. O., & Mitch, W. E. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.01.009 · Cited by 36
Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder
Calkin, C. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1659511 · Cited by 38
Li, L., Krznar, P., Erban, A., Agazzi, A., Martin-Levilain, J., Supale, S., Kopka, J., Zamboni, N., & Maechler, P. (2019) · Diabetes · doi:10.2337/db19-0131 · Cited by 36
Kang, K. A., Jun, D. W., Kim, M. S., Kwon, H., & Nguyen, M. H. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15626 · Cited by 35
Bidulescu, A., Dinh, P. C., Sarwary, S., Forsyth, E., Luetke, M. C., King, D. B., Liu, J., Davis, S., & Correa, A. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0511-z · Cited by 39
Faria, S. L., Santos, A., Magro, D. O., Cazzo, E., Assalin, H. B., Guadagnini, D., Vieira, F. T., Dutra, E. S., Saad, M. J. A., & Ito, M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04956-9 · Cited by 36
Shengir, M., Krishnamurthy, S., Ghali, P., Deschênes, M., Wong, P. Y. N., Chen, T., & Sebastiani, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i44.7046 · Cited by 37
Zaparolli, M. R., Carlos, L. D. O., Wagner, N. R. F., Felicidade, I., da Cruz, M. R., Taconeli, C. A., Fernandes, R., Filho, A. J. B., & Campos, A. C. L. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05222-2 · Cited by 36
Guo, H. Y., Wang, C., Jiang, B., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.554604 · Cited by 35
Cho, I.-J., Oh, D.-H., Yoo, J. H., Hwang, Y., Ahn, K. J., Chung, H.-Y., Jeong, S. W., Moon, J.-Y., Lee, S. H., Lim, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88872-7 · Cited by 36
Gijbels, A., Trouwborst, I., Jardon, K. M. C., Hul, G. B. J., Siebelink, E., Bowser, S. M., Yildiz, D., Wanders, L., Erdõs, B., Thijssen, D. H. J., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.694568 · Cited by 33
Lee, L., Hou, Y.-C., Hsieh, Y.-Y., Chen, Y., Shen, Y., Lee, I., Shih, M.-C. M., Hou, W., & Liu, H. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104653 · Cited by 35
Arai, T., Atsukawa, M., Tsubota, A., Kato, K., Abe, H., Ono, H., Kawano, T., Yoshida, Y., Tanabe, T., Okubo, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95581-8 · Cited by 36
Ruyvaran, M., Zamani, A., Mohamadian, A., Zarshenas, M. M., Eftekhari, M. H., Pourahmad, S., Abarghooei, E. F., Akbari, A., & Nimrouzi, M. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114590 · Cited by 36
Utzschneider, K. M., Younes, N., Rasouli, N., Barzilay, J. I., Banerji, M. A., Cohen, R. M., GONZALEZ, E. V., Ismail‐Beigi, F., Mather, K. J., Raskin, P., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002264 · Cited by 35
Tian, J., Bai, B., Gao, Z., Yang, Y., Wu, H., Wang, X., Wang, J., Li, M., & Tong, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.740236 · Cited by 37
Yu, J. H., Kim, R. E. Y., Jung, J., Park, S. Y., Lee, D. Y., Cho, H. J., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02581-4 · Cited by 42
Higher fasting triglyceride predicts higher risks of diabetes mortality in US adults
Wang, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01614-6 · Cited by 35
Haß, U., Herpich, C., Kochlik, B., Weber, D., Grune, T., & Norman, K. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1753-4 · Cited by 36
Peters, B. A., Xing, J., Chen, G.-C., Usyk, M., Wang, Z., McClain, A. C., Thyagarajan, B., Daviglus, M. L., Sotres‐Alvarez, D., Hu, F. B., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2022.11.020 · Cited by 38
Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations
Ebert, T., Kralisch, S., Wurst, U., Scholz, M. R., Stümvoll, M., Kovacs, P. L., Faßhauer, M., & Tönjes, A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.157 · Cited by 35
Gil‐Campos, M., Aguilera, C. M., Cañete, R., et al. (2010) · PubMed · doi:10.3305/nh.2009.24.5.4491 · Cited by 35
The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
Valderhaug, T. G., Hertel, J. K., Nordstrand, N., Dale, P. O., Hofsø, D., & Hjelmesaeth, J. S. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0040-5 · Cited by 35
Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues
Tzanela, M., Vassiliadi, D. A., Gavalas, N. G., Szabo, A., Margelou, E., Valatsou, A., & Vassilopoulos, C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03996.x · Cited by 35
Chiu, K. C., Chuang, L., & Yoon, C. (2001) · BMC Genetics · doi:10.1186/1471-2156-2-7 · Cited by 35
Anderson, A. S., Haynie, K. R., McMillan, R. P., Osterberg, K. L., Boutagy, N. E., Frisard, M. I., Davy, B. M., Davy, K. P., & Hulver, M. W. (2015) · Obesity · doi:10.1002/oby.21031 · Cited by 38
Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
Faghihnia, N., Mangravite, L. M., Chiu, S., Bergeron, N., & Krauss, R. M. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.118 · Cited by 36
Khanal, R. C., Howard, L. R., Wilkes, S. E., Rogers, T. J., & Prior, R. L. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2011.0212 · Cited by 35
Huan, Y., DeLoach, S. S., Keith, S. W., Goodfriend, T. L., & Falkner, B. E. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.09.005 · Cited by 33
Kawamoto, R., Kohara, K., Tabara, Y., Miki, T., & Otsuka, N. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no414 · Cited by 34
Midaoui, A. E., Ismael, M. A., Lu, H., Fantus, I. G., de Champlain, J., & Couture, R. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-090 · Cited by 35
Sharma, A. K., Bharti, S., Bhatia, J., Nepal, S., Malik, S., Ray, R., Kumari, S., & Arya, D. S. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.011 · Cited by 36
Vrbíková, J., Dvorakova, K., Grimmichová, T., Hill, M., Stanická, S., Cibula, D., Bendlová, B., Stárka, L., & Vondra, K. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.113 · Cited by 35
Kong, A. P. S., Choi, K. C., Cockram, C. S., Ho, C. S., Chan, M. H. M., Ozaki, R., Wong, G., Ko, G. T. C., So, W. Y., Tong, P. C. Y., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.014 · Cited by 35
Sharman, J. E., Haluska, B. A., Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.045 · Cited by 35
Hansen, T., Ahlström, H. K., Söderberg, S., Hulthe, J., Wikström, J., Lind, L., & Johansson, L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.007 · Cited by 35
Sanip, Z., Ariffin, F. D., Al-Tahami, B. A. M., Sulaiman, W. A. W., & Rasool, A. H. G. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.05.002 · Cited by 37
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
